DANAHER CORP

WASHINGTON, DC How do I update this listing?

Create Email Alert

Danaher Corp is based out of Washington. Danaher Corporation (Danaher) is engaged in the design, manufacture and marketing of professional, medical, industrial, commercial and consumer products. Danaher operates in four segments: Professional Instrumentation, Medical Technologies, Industrial Technologies, and Tools & Components. In January 2010, the Company announced that it has acquired 97% interest in Genetix Group plc. In February 2010, the Company completed the previously announced acquisition of AB SCIEX and Molecular Devices.Whalewisdom has at least 9 13D filings, 2 13G filings, and 523 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2018-04-17. The notice included securities offered of Equity

Contact Info

danaher corp
2200 PENNSYLVANIA AVE. N.W.
WASHINGTON DC    20037-1701

Business Phone: 2028280850
SEC SIC CODE:
3823-INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL
Current 13D/G Holdings
Stock Sector Shares Held Market Value Rank Source Source Date
Codex DNA Inc (DNAY) HEALTH CARE 2,294,167 24,777,003.60 1 13G 2021-12-31
IsoPlexis Corp (ISO) HEALTH CARE 1,976,801 18,166,801.19 2 13G 2021-12-31

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2018-04-17 D MANUFACTURING Equity INDEFINITE 12,907,700 INDEFINITE
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ALAN G. SPOON subscription required
    DIRECTOR
ANGELA S. LALOR subscription required
    EXECUTIVE OFFICER
BRIAN W. ELLIS subscription required
    EXECUTIVE OFFICER
DANIEL L. COMAS subscription required
    EXECUTIVE OFFICER
DANIEL A. RASKAS subscription required
    EXECUTIVE OFFICER
DONALD J. EHRLICH subscription required
    DIRECTOR
ELIAS A. ZERHOUNI subscription required
    DIRECTOR
JOAKIM WEIDENMANIS subscription required
    EXECUTIVE OFFICER
JOHN T. SCHWIETERS subscription required
    DIRECTOR
LINDA HEFNER FILLER subscription required
    DIRECTOR
MITCHELL P. RALES subscription required
    EXECUTIVE OFFICER DIRECTOR
RAINER M. BLAIR subscription required
    EXECUTIVE OFFICER
RAYMOND STEVENS, PH.D. subscription required
    DIRECTOR
ROBERT S. LUTZ subscription required
    EXECUTIVE OFFICER
STEVEN M. RALES subscription required
    EXECUTIVE OFFICER DIRECTOR
TERI LIST-STOLL subscription required
    DIRECTOR
THOMAS P. JOYCE, JR. subscription required
    EXECUTIVE OFFICER DIRECTOR
WALTER G. LOHR, JR. subscription required
    DIRECTOR
WILLIAM K. DANIEL II subscription required
    EXECUTIVE OFFICER
WILLIAM H. KING subscription required
    EXECUTIVE OFFICER

Elevate your investments